INS and breast carcinoma: Statins similarly failed to inhibit HDAC activity in MDA-MB-231 breast carcinoma cells and BRIN-BD11 insulin-secreting cells, while sodium butyrate and TSA showed significant inhibition (p < 0.0001) (Figure 2b,c).